Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Real-time collection of data on patients with COVID-19 and thrombosis and/or haemorrhage has aided the development of thromboembolism prophylaxis guidelines at the Royal Surrey County Hospital during the COVID-19 pandemic

Georgina Simpson and Matthew Rogers
Download PDF
DOI: https://doi.org/10.7861/clinmed.21-2-s51
Clin Med March 2021
Georgina Simpson
ARoyal Surrey County Hospital, Guildford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Rogers
ARoyal Surrey County Hospital, Guildford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Introduction

As the COVID-19 pandemic progressed, it became apparent that worldwide these patients had a predisposition to thrombotic complications such as pulmonary embolisms, deep vein thromboses and circuit clotting in those receiving renal replacement therapy.1 At the start of the epidemic in the UK there was little trial evidence, and no national or international guidelines, to assist clinicians in optimising venous thromboembolism prevention and treatment for COVID-19 patients. It was therefore necessary to develop local guidelines, and to inform and fine-tune these we collected data on all patients with COVID-19 and thrombosis as the epidemic progressed.

Method

Patients were selected based on either having a positive swab or clinical/imaging features consistent with COVID-19 infection. From this cohort we identified those who had developed thromboembolism, confirmed on imaging, and/or patients who had suffered bleeding events. To identify these patients we liaised with various teams within the hospital including the intensive care unit, medicine and palliative care.

Results and discussion

We identified 25 patients based on our selection criteria. There were 21 thrombosis cases (17=pulmonary emboli, 2=deep vein thrombosis, 2=other thrombosis) and 12 bleeding event cases (2=minor (no intervention required), 9=clinically relevant but non-major (requiring some intervention but not life-threatening), 1=major (life-threatening)).

Our study generated several key findings. The majority of thromboses were pulmonary emboli (17/21) and the majority of thromboses (13/21) occurred on or before admission and therefore patients were not receiving any anticoagulation at the time (Fig 1). Not a single thrombosis occurred post-discharge, suggesting that post-discharge prophylaxis is not likely to be beneficial (Fig 2). This is in agreement with results from a larger study from King's College Hospital.2 Based on this finding, we removed the recommendation for routine post-discharge prophylaxis for COVID-19 patients from our guideline. There was a wide spread in D-dimer level (268–100,000 ng/mL), suggesting that D-dimer levels do not correlate well with thrombotic risk. We therefore removed ‘high D-dimer’ from our list of indications for considering escalated prophylactic dosing of low-molecular-weight heparin. The majority of bleeding events occurred while patients were on therapeutic unfractionated heparin (UFH). This may in part have been due to the fact these patients were the most unwell, but difficulties with monitoring UFH treatment in patients with COVID-19 may also have contributed: activated partial thromboplastin times may be misleading due to high levels of clotting factors in these patients. We have therefore moved to monitoring UFH treatment using anti-Xa levels.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Anticoagulation being received at time of thrombosis diagnosis.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Time when thrombosis was diagnosed.

Conclusion

By using real-time data collection during the course of the COVID-19 outbreak, we have been able to develop and refine our response in terms of our local venous thromboembolism guidelines. We are mindful of the dynamic situation surrounding the COVID-19 pandemic and plan to continue enhancing our guidelines as necessary.

Conflicts of interest

None declared.

  • © Royal College of Physicians 2021. All rights reserved.

References

  1. ↵
    1. Helms J
    , Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46:1089–98.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Roberts LN
    , Whyte MB, Georgiou L, et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood 2020;136:1347–50.
    OpenUrlCrossRefPubMed
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Real-time collection of data on patients with COVID-19 and thrombosis and/or haemorrhage has aided the development of thromboembolism prophylaxis guidelines at the Royal Surrey County Hospital during the COVID-19 pandemic
Georgina Simpson, Matthew Rogers
Clinical Medicine Mar 2021, 21 (Suppl 2) 51-52; DOI: 10.7861/clinmed.21-2-s51

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Real-time collection of data on patients with COVID-19 and thrombosis and/or haemorrhage has aided the development of thromboembolism prophylaxis guidelines at the Royal Surrey County Hospital during the COVID-19 pandemic
Georgina Simpson, Matthew Rogers
Clinical Medicine Mar 2021, 21 (Suppl 2) 51-52; DOI: 10.7861/clinmed.21-2-s51
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Method
    • Results and discussion
    • Conclusion
    • Conflicts of interest
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A socially distanced and digitally enhanced COVID-19 rehabilitation programme
  • Reducing unnecessary and non-indicated resuscitation attempts in COVID-19 oncology patients by improving documentation of resuscitation plan on admission including early recognition of appropriate DNACPR
  • Long-term COVID-19 complications: a multidisciplinary clinic follow-up approach
Show more COVID-19

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians